Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
40 hedge funds and large institutions have $3.85M invested in Surgalign Holdings, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 43 closing their positions.
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
48% less funds holding
Funds holding: 77 → 40 (-37)
71% less capital invested
Capital invested by funds: $13.3M → $3.85M (-$9.47M)
86% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWS
Atria Wealth Solutions
New York
|
+$504K |
| 2 |
Renaissance Technologies
New York
|
+$412K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$284K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$243K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$139K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.24M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.03M |
| 3 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
-$970K |
| 4 |
EP
Eversept Partners
New York
|
-$479K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$289K |
SRGA Hedge Fund Activity: Q2 2022 in Review
40 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2022, worth a combined $3.85M — down 71% from $13.3M a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of SRGA and 6 opened new positions — a net loss of 37 holders — while 15 trimmed existing stakes and 13 added.
The largest buyer was Atria Wealth Solutions, adding an estimated $504K. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $2.24M sold.
- 40 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2022, down from 77 in Q1 2022.
- Funds reported $3.85M of Surgalign Holdings, Inc. Common Stock stock for Q2 2022, down 71% quarter-over-quarter.
- 6 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2022 and 43 closed out, a net change of -37 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2022 was Atria Wealth Solutions, an estimated $504K added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2022 was Stonepine Capital Management, an estimated $2.24M sold.
Based on aggregated 13F filings for Q2 2022.